Normal Reference Values in Han Adults of Extremity Arterial Structure and Hemodynamics by High-frequency Ultrasound (NOVAEA-HFUS)

July 23, 2023 updated by: Chunyan Ma, First Hospital of China Medical University

Normal Reference Values in Han Adults of Extremity Arterial Structure and Hemodynamics by High-frequency Ultrasound: a Multi-center Study in China

In recent years, high-frequency ultrasound, due to its higher resolution, can clearly display the superficial vascular structure and blood flow, and can detect vascular lesions early, providing a new non-invasive tool for clinical observation of the structure and blood flow of the extremity artery. The purpose of this multi-center study is to establish the normal value of high frequency ultrasound for the structure and blood flow of the extremity arteries of Chinese Han adults, and to explore the influencing factors, so as to provide a quantitative reference for the early diagnosis, degree evaluation and curative effect observation of the structure and blood flow of the extremities.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The extremity artery is the peripheral blood vessel of the whole body, and it is often involved early in the diseases that are easy to damage the small vessels, such as atherosclerosis and connective tissue diseases. Early lower limb atherosclerosis mainly occurs in the dorsal foot artery, which is commonly seen in people with diabetes and long-term smoking. Connective tissue diseases such as systemic sclerosis and systemic lupus erythematosus also mainly involve small blood vessels, and vascular lesions may appear earlier than those of other specific organs such as heart and lung. Because of its shallow location, the extremity artery can be better used as a screening site for vascular diseases, and it is the window for early reaction of vascular diseases.However, the early stage of extremity artery disease is easy to be ignored, and patients often have pain and numbness of the affected limb. When the disease is severe, it can lead to ulcer not healing, and even limb gangrene and amputation, which greatly affects the quality of life and brings huge troubles and economic pressure to the patients. Therefore, early diagnosis of extremity arterial lesions is of great significance for early diagnosis of microvascular injury diseases such as atherosclerosis and connective tissue diseases, reducing the incidence of complications, and reducing the rate of amputation and mortality.

Ultrasound is a non-invasive imaging technique widely used in clinic. In recent years, with the development of ultrasound technology, the frequency of ultrasonic probes has been increasing. Because of its higher resolution, high-frequency ultrasound can clearly display the superficial vascular structure and blood flow, detect vascular lesions early, and accurately quantify the degree of stenosis, providing a new and beneficial tool for clinical observation of the structure and blood flow of the extremity artery. The purpose of this multi-center clinical study was to establish the normal value of high frequency ultrasound for the structure and blood flow of the extremities of Chinese Han adults, and to explore its influencing factors, so as to provide a quantitative reference for the early diagnosis, degree evaluation and curative effect observation of the structure and blood flow of the extremities.

Study Type

Observational

Enrollment (Estimated)

540

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Chinese healthy Han adults

Description

Inclusion Criteria:

  1. Han nationality;
  2. Ages 18-79;
  3. Normal blood pressure (139-90/89-60mmHg);
  4. Body mass index < 30 kg/m2;
  5. Blood routine, fasting blood glucose, blood lipid, liver and kidney function, electrocardiogram were normal;
  6. No history of cyanosis of hands and feet, cold stimulation without discomfort, no Raynaud phenomenon has occurred in all parts of the body;
  7. No cardiovascular disease, diabetes, rheumatic connective tissue disease, serious liver and kidney dysfunction;
  8. No history of drug use affecting cardiovascular system.

Exclusion Criteria:

  1. Patients with hypertension, diabetes, hyperthyroidism, arrhythmia and other diseases;
  2. Patients with systemic lupus erythematosus, polymyositis, rheumatoid arthritis and other connective tissue diseases;
  3. A history of related blood diseases;
  4. Have taken vasoconstrictor drugs in the past 1 month;
  5. Gangrene of fingers and toes or history of trauma or surgery;
  6. Have a history of handicraft, hammering, digging and other related work;
  7. Have a long history of smoking and drinking;
  8. Peripheral vascular disease, arterial occlusion can not detect blood flow signal;
  9. Unable to cooperate with the examiner.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intima thickness of dorsalis pedis artery and proper palmar digital artery
Time Frame: 1 day
Intima thickness reflects the changes of vascular wall structure and is used for early evaluation of arterial disease.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood flow velocity of dorsalis pedis artery and proper palmar digital artery
Time Frame: 1 day
Blood flow velocity reflects hemodynamic changes and is used for early evaluation of arterial disease.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lixin Jiang, PHD, Shanghai Jiao Tong University School of Medicine
  • Principal Investigator: Xinhua Ye, PHD, The First Affiliated Hospital with Nanjing Medical University
  • Principal Investigator: WeiDong Ren, PHD, Shengjing Hospital
  • Principal Investigator: Xin Guan, PHD, Tianjin Chest Hospital
  • Principal Investigator: Hongning Yin, PHD, The Second Hospital of Hebei Medical University
  • Principal Investigator: Xiaoshan Zhang, PHD, The Affiliated Hospital of Inner Mongolia Medical University
  • Principal Investigator: Yuhong Zhang, PHD, The Second Affiliated Hospital of Dalian Medical University
  • Principal Investigator: Qingxiong Yue, PHD, Dalian Municipal Central Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2023

Primary Completion (Estimated)

August 31, 2024

Study Completion (Estimated)

August 31, 2025

Study Registration Dates

First Submitted

July 23, 2023

First Submitted That Met QC Criteria

July 23, 2023

First Posted (Actual)

August 1, 2023

Study Record Updates

Last Update Posted (Actual)

August 1, 2023

Last Update Submitted That Met QC Criteria

July 23, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteer

Clinical Trials on high-frequency ultrasound

Subscribe